Results 131 to 140 of about 47,907 (235)
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
Francesca Farina, Alessandra Stasia, Carlo Gambacorti-Passerini Department of Health Sciences, University of Milano Bicocca, Monza, Italy Abstract: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase protein implicated in a variety of ...
Farina F +2 more
doaj
Intrasinusoidal ALK-positive anaplastic large cell lymphoma. [PDF]
Braye E, de Leval L.
europepmc +1 more source
Anaplastic large-cell lymphoma mimicking cellulitis in an 8-year-old boy. [PDF]
Bourque M, Coulombe J.
europepmc +1 more source
Primary cutaneous ALK-negative anaplastic large cell lymphoma. [PDF]
Mishra P, Mishra C, Dash S.
europepmc +1 more source
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study [PDF]
et al, +2 more
core +1 more source
Advances and updates in pediatric anaplastic large cell lymphoma. [PDF]
Marks LJ, Lowe E, Kamdar K.
europepmc +1 more source
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas [PDF]
Bartlett, Nancy L +6 more
core +2 more sources
Cutaneous involvement of systemic anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Tanmoy Kumar Mandal +4 more
doaj +1 more source
Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma with Colon Involvement
Yuko Sakakibara +9 more
doaj +1 more source

